IL21R expressing CD14 + CD16 + monocytes expand in multiple myeloma patients leading to increased osteoclasts
Open Access
- 5 January 2017
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 102 (4), 773-784
- https://doi.org/10.3324/haematol.2016.153841
Abstract
Bone marrow monocytes are primarily committed to osteoclast formation. It is, however, unknown whether potential primary alterations are specifically present in bone marrow monocytes from patients with multiple myeloma, smoldering myeloma or monoclonal gammopathy of undetermined significance. We analyzed the immunophenotypic and transcriptional profiles of bone marrow CD14+ monocytes in a cohort of patients with different types of monoclonal gammopathies to identify alterations involved in myeloma-enhanced osteoclastogenesis. The number of bone marrow CD14+CD16+ cells was higher in patients with active myeloma than in those with smoldering myeloma or monoclonal gammopathy of undetermined significance. Interestingly, sorted bone marrow CD14+CD16+ cells from myeloma patients were more pro-osteoclastogenic than CD14+CD16-cells in cultures ex vivo. Moreover, transcriptional analysis demonstrated that bone marrow CD14+ cells from patients with multiple myeloma (but neither monoclonal gammopathy of undetermined significance nor smoldering myeloma) significantly upregulated genes involved in osteoclast formation, including IL21R. IL21R mRNA over-expression by bone marrow CD14+ cells was independent of the presence of interleukin-21. Consistently, interleukin-21 production by T cells as well as levels of interleukin-21 in the bone marrow were not significantly different among monoclonal gammopathies. Thereafter, we showed that IL21R over-expression in CD14+ cells increased osteoclast formation. Consistently, interleukin-21 receptor signaling inhibition by Janex 1 suppressed osteoclast differentiation from bone marrow CD14+ cells of myeloma patients. Our results indicate that bone marrow monocytes from multiple myeloma patients show distinct features compared to those from patients with indolent monoclonal gammopathies, supporting the role of IL21R over-expression by bone marrow CD14+ cells in enhanced osteoclast formation.Keywords
This publication has 49 references indexed in Scilit:
- Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20Leukemia, 2015
- Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myelomaLeukemia, 2013
- Immature dendritic cells in multiple myeloma are prone to osteoclast‐like differentiation through interleukin‐17A stimulationBritish Journal of Haematology, 2013
- Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma: A Review of the Current Understanding of Epidemiology, Biology, Risk Stratification, and Management of Myeloma Precursor DiseaseClinical Cancer Research, 2013
- JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL productionArthritis & Rheumatism, 2012
- CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritisArthritis Research & Therapy, 2010
- Autocrine Regulation of IL-21 Production in Human T LymphocytesPublished by The American Association of Immunologists ,2008
- The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNFThe Journal of Immunology, 2002
- Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor ComplexPublished by The American Association of Immunologists ,2001
- Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsiesBlood, 1996